HealthCore is a proud sponsor of ISPOR 2022: the leading global conference for health economics and outcomes research! Visit us at Booth #500 (or virtually), connect with our experts, and see our latest research.
Both in-person and virtual conference registration includes extended access to all session playback recordings as well as virtual posters and networking through June 17, 2022. For more information, please visit https://www.ispor.org/conferences-education/conferences/upcoming-conferences/ispor-2022.
Workshop
Concurrent Breakout Session 5 | Tuesday, May 17 | 1:30–2:30 pm ET
Discussion Leader: Michael Grabner, PhD1
Discussants: Nilesh Gangan, PhD1, Susan dosReis, PhD2
1HealthCore, Inc., Wilmington, DE, USA, 2University of Maryland School of Pharmacy, Baltimore, MD, USA
HealthCore ISPOR 2022 Causality Workshop [PDF]
Session | Topic | Title | Authors | Affiliations |
---|---|---|---|---|
Monday, May 16 Poster Session 1 12:15 – 1:15 PM EDT |
CLINICAL OUTCOMES / DIABETES / ENDOCRINE / METABOLIC DISORDERS |
CO30 | Clinical Experiences of Type 2 Diabetes (T2DM) Patients Initiating Oral Semaglutide |
Dunn TJ1, Swift C1, Guesnier A1, Noone J1, Willey V2 |
1Novo Nordisk Inc., Plainsboro, NJ, USA, 2HealthCore, Inc., Wilmington, DE, USA |
Monday, May 16 Poster Session 1 12:15 – 1:15 PM EDT |
METHODOLOGICAL & STATISTICAL RESEARCH / NO ADDITIONAL DISEASE & CONDITIONS / SPECIALIZED TREATMENT AREAS |
Hoffman S1, Gangan N1, Chen X2, Smith JL1, Tave A1, Yang Y1, dosReis S3, Grabner M1 |
1HealthCore, Inc., Wilmington, DE, USA, 2Anthem, Inc., Indianapolis, IN, USA, 3University of Maryland School of Pharmacy, Baltimore, MD, USA |
|
Tuesday, May 17 Poster Session 3 12:15 – 1:15 PM EDT |
CLINICAL OUTCOMES / DIABETES / ENDOCRINE / METABOLIC DISORDERS |
Dunn TJ1, Swift C1, Guesnier A1, Noone J1, Willey V2 |
1Novo Nordisk Inc., Plainsboro, NJ, USA, 2HealthCore, Inc., Wilmington, DE, USA |
|
Tuesday, May 17 Poster Session 3 12:15 – 1:15 PM EDT |
ECONOMIC EVALUATION / DIABETES / ENDOCRINE / METABOLIC DISORDERS |
Chung H1, Thomas N1, Willey V1, Kong SX2, Singh R2, Farej R2, Williamson T2 |
1HealthCore, Inc., Wilmington, DE, USA, 2Bayer U.S. LLC, Whippany, NJ, USA |
|
Tuesday, May 17 Poster Session 4 5:30 – 6:30 PM EDT |
REAL WORLD DATA & INFORMATION SYSTEMS / NO ADDITIONAL DISEASE & CONDITIONS / SPECIALIZED TREATMENT AREAS |
Avula R1, Grabner M1, Eshete B1, Stanek E2, Willey V1 |
1HealthCore, Inc., Wilmington, DE, USA, 2Anthem, Inc., Indianapolis, IN, USA |
|
Wednesday, May 18 Poster Session 5 9:00 – 10:00 AM EDT |
CLINICAL OUTCOMES / MEDICAL DEVICES |
Pham T1, Chen X1, Talavera M1, Napier M1, Willey V2 |
1Anthem, Inc., Indianapolis, IN, USA, 2HealthCore, Inc., Wilmington, DE, USA |